Baylor College of Medicine

Omnipod Horizon Pivotal Study (H-46880)

Description

Content

Study Goal(s): This study is a single-arm, multi-center, prospective clinical study to evaluate the effectiveness of the Omnipod Horizon Automated Glucose Control System in children aged 6-13.9 years and adults aged 14-70 years. 

Eligibility Criteria: None

Investigators: Daniel DeSalvo, M.D. (site principal investigator), Siripoom McKay, M.D. (co-investigator)

Supported by: Insulet 

Contact

Carolina.villegas@bcm.edu

IRB: H-46880

Status:

Active

Created:

Back to topback-to-top